Quanta Dialysis Technologies
Jonathan Isenburg is Interim Chief Financial Officer at Quanta. Jonathan joins Quanta from Conventus Flower where he served as that Company’s CFO and COO. While at Conventus Flower, Jonathan worked closely with the CEO to acquire Flower Orthopedics and the FlexThread Intramedullary Nailing Platform. Prior to joining Conventus Flower, Jonathan led Infraredx through a dual track IPO process that culminated in its sale to the Nipro Corporation.
Jonathan began his career at PwC and was a manager in the Financial Advisory Services practice at RSM. Jonathan earned an MS in Investment Management from Boston University and a BBA in Accounting from UMASS Amherst. He was formerly licensed as a CPA.
This person is not in any teams
This person is not in any offices
Quanta Dialysis Technologies
Quanta aims to improve the lives of dialysis patients by providing advanced haemodialysis solutions for use in a range of care settings. SC+ is designed with you in mind and provides flexibility for patients, carers and providers. Our mission at qua...